Minimal residual disease monitoring after allogeneic transplantation may help to individualize post-transplant therapeutic strategies in acute myeloid malignancies

1. Díez-Campelo, M.
2. Pérez-Simón, J.A.
3. Pérez, J.
4. Alcoceba, M.
5. Richtmon, J.
6. Vidriales, B.
7. Miguel, J.S.